Sign Up

Sign up to our social GMP Questions and Answers Engine to ask and answer questions, and connect with other professionals.

Have an account? Sign In
or use


Have an account? Sign In Now

Sign In

Login to our social GMP Questions and Answers Engine to ask and answer questions and connect with other professionals.

Sign Up Here
or use

Forgot Password?

Don't have account, Sign Up Here

Forgot Password

Lost your password? Please enter your email address. You will receive a link and will create a new password via email.


Have an account? Sign In Now
You must login to ask question.

or use

Forgot Password?

Need An Account, Sign Up Here
Qualistery – GMP Knowledge Provider Logo Qualistery – GMP Knowledge Provider Logo
Sign InSign Up

Qualistery – GMP Knowledge Provider

Qualistery – GMP Knowledge Provider Navigation

  • Home
  • GMP Learning
    • Live GMP Webinars
    • Webinar Recordings
  • Resources
    • Articles
    • Podcast
  • Speaking & Sponsorship
    • Speaking Partners (Organization)
    • Event Sponsorship
    • Speaking and Training Opportunities For GxP Experts
  • Contact
  • My Account
Search
Ask A Question

Mobile menu

Close
Ask a Question
  • Home
  • GMP Learning
    • Live GMP Webinars
    • Webinar Recordings
  • Resources
    • Articles
    • Podcast
  • Speaking & Sponsorship
    • Speaking Partners (Organization)
    • Event Sponsorship
    • Speaking and Training Opportunities For GxP Experts
  • Contact
  • My Account
Home/ Questions/Q 812
Next
In Process
Adv
Qualistery
  • 0
QualisteryLevel 2
Asked: September 9, 20212021-09-09T07:36:10+02:00 2021-09-09T07:36:10+02:00In: Manufacturing

What manufacturing contamination risks are presented by the different pathogenic agents?

  • 0
What manufacturing contamination risks are presented by the different pathogenic agents?
  • 2 2 Answers
  • 136 Views
  • 0 Followers
  • 0
Answer
Share
  • Facebook
    Adv

    2 Answers

    • Voted
    • Oldest
    • Recent
    • Random
    1. Qualistery Level 2
      2021-09-09T17:02:27+02:00Added an answer on September 9, 2021 at 5:02 pm

      Manufacturing contamination risks presented by the different pathogenic agents can include the following: Vegetative Bacteria Vegetative bacteria are actively growing and reproducing bacteria. If there are no steps in the manufacturing process to kill vegetative bacteria, they can proliferate and accumulate during drug ingredient processing. Toxin-Producing Microorganisms Several genera and species of microorganisms are capable of producing toxins.

      Microbial toxins can be divided into two general groups: exotoxins and endotoxins. An exotoxin is a soluble protein excreted by a microorganism, including bacteria, fungi, algae, and protozoa. Exotoxins can include heat-stable toxins that remain active at temperatures as high as 100°C or heat-labile toxins that are readily inactivated by heat treatment. Exotoxins, especially heat-stable exotoxins, can remain in the ingredient throughout the manufacturing process and adversely affect patient health. An endotoxin is a component of the outer membrane of a Gram-negative bacterium. Unlike exotoxins, endotoxins are only released when the organisms are disrupted or destroyed. Endotoxins are heat- and chemical-resistant and, if injected, may induce reactions including febrile effect, hypotension, and shock. Spore-Forming Bacteria Spore-forming bacteria can be difficult to eliminate from the manufacturing environment because the spores may be extremely resistant to heat, freezing, extreme pH, desiccation, and chemicals. Spore-forming bacteria can produce exotoxins and can remain dormant without nutrients for extended periods.

      Spores can be resistant to harsh manufacturing processes that will kill vegetative bacteria. When dormant spores are reintroduced into an acceptable germination environment they can become active reproductive vegetative cells. Once spores germinate and begin reproducing as vegetative cells, production of exotoxins can occur in a short period of time. Fungi/Molds Molds are a subset of fungi that reproduce by releasing spores into the air which, if they land on a moist nutrient source or animal tissue, can germinate. Some species of molds produce toxic byproducts called mycotoxins. Mycotoxins can accumulate in animal tissues, rendering the affected organs/tissues unfit for use as a source of starting material for the production of animal-derived drug ingredients. It is important to prevent molds from growing in drug ingredients and when feasible and valuable remove all molds that may contaminate such ingredients. Yeasts, another type of fungi, can also be pathogenic or cause spoilage of an ingredient.

      Viruses Although a virus can only multiply within its host, the inadvertent use of material from virus-infected animals or contact of the drug ingredient with virus-contaminated surfaces can transmit viral particles to patients. Virus survival rates differ based on virus type and variables associated with surface materials that become contaminated. On hard, nonporous surfaces, some virus species can survive and remain transmissible for days or weeks. The probability of an animal virus contaminating an animal-derived ingredient will depend on the viral load of the raw material (e.g., tissue, glands, blood) and the viral clearance capability of the drug ingredient manufacturing process. Both of these factors should be considered when assessing the risk of viral contamination of the ingredient. Internal Animal Parasites Transmission of internal parasites occurs from host to host through the consumption of contaminated food or water.

      Parasites live and reproduce within the tissues and organs of infected hosts and are often excreted in feces. Government inspectors are trained to look for internal parasites and prevent unhealthy animals from entering the food supply. Animals deemed fit for food consumption are inspected and certified as healthy. Prions Protection from prion contamination includes obtaining bovine meat and meat by-products from animals not infected with bovine spongiform encephalopathy and protecting against contamination of the product with high-risk tissues, especially the brain and spinal cord tissue.

      Drug manufacturers importing bovine material into the United States should be familiar with and adhere to all import eligibility requirements and government regulations pertaining to food and drugs. It is important that farms, slaughterhouses, and renderers observe government regulations prohibiting the use of unhealthy animals in the food supply. Animals deemed fit for food consumption are normally inspected and certified as healthy in many countries.

      • 0
      • Reply
      • Share
        Share
        • Share on Facebook
        • Share on Twitter
        • Share on LinkedIn
        • Share on WhatsApp
    2. Marc García Gómez Level 1
      2021-10-03T12:31:10+02:00Added an answer on October 3, 2021 at 12:31 pm

      Pharmaceutical manufacturers must demonstrate that bacterial, fungal, and yeast contamination is under control (and their spores). A disinfectant rotation program should include a sporicide capable of eliminating endospores and exospores. The sporicide must be used periodically depending on the trends detected in microbiological identification when the environmental monitoring is performed.

      Pharmaceutical authorities are putting the focus of attention on fungal and bacterial spore contaminations, with cases of batch recall for these reasons.

      To avoid the appearance of spores in the manufacturing processes, it is necessary to have also a cleaning program (not only disinfection) that eliminates biocide and manufacturing processes residues. These residues lead to corrosion on surfaces, so they must be removed with a validated cleaning program including a pharmaceutical grade detergent.

      Bacterial endotoxins can only be removed with dry heat (200-250ºC), not with biocides. Depyrogenation ovens must be properly maintained so that the corrosion does not affect their operation.

      As far as possible, pharmaceutical manufacturers should request official certificates from their suppliers that their materials do not come from animal origin and, if they do have animal origin, carry out an appropriate risk analysis.

      • 0
      • Reply
      • Share
        Share
        • Share on Facebook
        • Share on Twitter
        • Share on LinkedIn
        • Share on WhatsApp

    Leave an answer
    Cancel reply

    You must login to add an answer.

    or use

    Forgot Password?

    Need An Account, Sign Up Here
    Adv

    Sidebar

    Ask A Question

    Stats

    • Questions 103
    • Answers 117
    • Best Answer 1
    • Users 71
    • Popular
    • Answers
    • Anonymous

      tablet hardness

      • 5 Answers
    • Qualistery

      What is Data Governance?

      • 3 Answers
    • Qualistery

      What is data life cycle?

      • 2 Answers
    • Md.Mahamudul Hossain Robin
      Md.Mahamudul Hossain Robin added an answer It is Completely depends on the design . There is… December 7, 2022 at 4:53 am
    • Yan Kugel
      Yan Kugel added an answer Dear Nadia, a recall is an action which the manufacturer… October 8, 2021 at 5:20 pm
    • Marc García Gómez
      Marc García Gómez added an answer Pharmaceutical manufacturers must demonstrate that bacterial, fungal, and yeast contamination… October 3, 2021 at 12:31 pm

    Related Questions

    • Qualistery

      How many containers of each component from each shipment must ...

      • 2 Answers
    • Qualistery

      What are the Specs and Requirements for conducting visual inspection ...

      • 1 Answer
    • Qualistery

      Is analytical testing required at product changeover, on equipment in ...

      • 1 Answer

    Top Members

    Yan Kugel

    Yan Kugel

    • 0 Questions
    • 88 Points
    Level 2
    Qualistery

    Qualistery

    • 85 Questions
    • 78 Points
    Level 2
    Shashi Ravi Suman Rudrangi, RPh

    Shashi Ravi Suman Rudrangi, RPh

    • 0 Questions
    • 33 Points
    Level 1

    Trending Tags

    Active Pharmaceutical Ingredient Airlock ALCOA+ analytical api APIs archiving A true copy audit trail Authorized Person Batch Batch Records Batch Recovery batch reworking Bracketing Calibration capa CGMP Change Control Clean Area cleaning cold chain monitoring Confirmation Testing Consignment contact lens solution Contamination Control Strategy Corrective Action Cross Contamination Data Governance data life cycle Delivery Design Space document retention schedule Drug Master File effectiveness electronic signature finished Pharmaceutical Product flexible intravenous glass GMP gmp&iso 9001 Good Manufacturing Practices good practices (GxP) hbel HBELs healthbased exposure limit health based exposure limit in-process control (IPC) In Process Control InterCompany Transfer Intermediate Product lamellae Large Volume Parenterals manufacturers manufacturing Marketing Authorization medical device medicinal metadata Operational Qualification Packaging Packaging Material pathogenic Performance Qualification Pharmaceutical manufacturers Pharmaceutical Manufacturing Pharmaceutical Product Pharmaceutical Production Pharmacopeia pq PQR process validation Product products QA QC Qualification Quality Assurance Quality Control Quality Planning quality policy quality risk management (QRM) Quality Unit Quarantine question raw material Reconciliation Reprocessing Sampling Self Contained Area single product solution bags sop special Specification Standard Operating Procedure starting material supplier qualifications supplier quality suppliers technology transfer usp Validation validation batches Validation batches in a Technology transfer Validation Master Plan validation report vp vr

    Explore

    • Home
    • Add group
    • Groups page
    • Communities
    • Questions
      • New Questions
      • Trending Questions
      • Must read Questions
      • Hot Questions
    • Polls
    • Tags
    • Badges

    Footer

    Qualistery - GMP Knowledge Provider

    Qualistery is a GMP knowledge database, and a social Questions & Answers engine which will help you dominate the arena.

    Company

    • About Us
    • Contact Us

    Legal

    • Impressum – Legal Disclosure
    • Privacy Policy
    • Cookie Policy
    • Terms and Conditions
    • Disclaimer

    Services

    • GMP Online Education

    GMP Resources

    • Articles
    • Podcast

    Follow

    © 2022 Qualistery. All Rights Reserved

    Insert/edit link

    Enter the destination URL

    Or link to existing content

      No search term specified. Showing recent items. Search or use up and down arrow keys to select an item.